Detalhe da pesquisa
1.
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Br J Haematol
; 198(1): 103-113, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277855
2.
Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network.
Haematologica
; 106(1): 39-45, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879328
3.
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature.
Hematol Oncol
; 38(5): 823-826, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979282
4.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
Am J Hematol
; 95(12): 1466-1472, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777149
5.
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.
Br J Cancer
; 121(2): 150-156, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209327
6.
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.
Hematol Oncol
; 37(4): 447-455, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385337
7.
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia.
Hematol Oncol
; 36(1): 366-369, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971495
8.
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
Br J Haematol
; 185(1): 193-197, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29974955
9.
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases.
Hematol Oncol
; 36(5): 801-803, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30110712
10.
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.
Front Oncol
; 13: 1212752, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37427126
11.
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.
Haematologica
; 102(4): e140-e143, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27927770
12.
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia.
Hematol Oncol
; 35(4): 925-928, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641225
13.
Sequential allogeneic transplantation and ruxolitinib maintenance for a synchronous PCM1-JAK2 positive myeloid sarcoma and acute B-lymphoblastic leukemia.
Clin Case Rep
; 10(1): e05212, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028141
14.
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.
Curr Oncol
; 30(1): 274-283, 2022 12 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661671
15.
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience.
Leuk Res
; 114: 106803, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150967
16.
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 13(21)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771616
17.
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.
Haematologica
; 100(12): e515-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26294735
18.
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia.
Onco Targets Ther
; 13: 9679-9688, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33061448
19.
Multifocal recurrent neuralgic amyotrophy in an immunocompromised patient.
J Neurol
; 271(3): 1080-1083, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184820
20.
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments.
Clin Lymphoma Myeloma Leuk
; 19(10): 678-685.e4, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371221